Trading Volumes in September Down Year-over-Year; Rebound From August 2012 Levels
New York, October 10, 2012– NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for September 2012[1]. Trading volumes in September 2012 were down year-over-year, but rebounded across the four principal trading venues from lower levels recorded in August 2012.
Highlights
- NYSE Euronext global derivatives ADV in September 2012 of 7.7 million contracts decreased 19.4% compared to September 2011, but increased 19.8% from August 2012 levels.
- NYSE Euronext European derivatives products ADV in September 2012 of 3.5 million contracts decreased 28.2% compared to September 2011, but increased 6.5% from August 2012. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 20.9% compared to September 2011, but increased 30.6% from August 2012 levels.
- NYSE Euronext U.S. equity options ADV of 4.1 million contracts in September 2012 decreased 10.2% compared to September 2011 levels, but increased 33.5% from August 2012. NYSE Euronext’s U.S. options exchanges accounted for 26.0% of total U.S. consolidated equity options trading in September 2012, down from 26.8% in September 2011, but up from 24.8% in August 2012.
- NYSE Liffe U.S. ADV of approximately 83,700 contracts decreased 26.2% compared to September 2011, but increased 32.4% versus August 2012.
- NYSE Euronext European cash products ADV of 1.4 million transactions in September 2012 decreased 24.2% compared to September 2011, but increased 31.3% from August 2012 levels.
- NYSE Euronext U.S. cash products handled ADV of 1.7 billion shares in September 2012 decreased 34.7% compared to September 2011, but increased 15.4% compared to August 2012. NYSE Euronext’s Tape A matched market share in September 2012 was 31.1%, down from 36.3% in September 2011 and down from 31.6% in August 2012.
- The preliminary average net revenue per transaction type (as defined below) for each of the primary trading venues in the third quarter of 2012 is included below:
|
|
|
|
Preliminary |
|---|---|---|---|
|
Trading Venue |
3Q11 |
2Q12 |
3Q12 |
|
European Derivatives (ex. Bclear)1 |
$0.679 |
$0.674 |
$0.65 |
|
U.S. Derivatives2 |
$0.154 |
$0.148 |
$0.14 |
|
European Cash3 |
$0.635 |
$0.519 |
$0.53 |
|
U.S. Cash4 |
$0.038 |
$0.043 |
$0.039 |
|
1 Average net revenue per contract, excluding Bclear. |
|
|
|
|
2 Average net revenue per contract. Excludes NYSE Liffe U.S. trading volume. |
|
||
|
3 Average net revenue per transaction. |
|
|
|
|
4 Average net revenue per 100 shares handled. |
|||
Cash Trading
European Cash
- NYSE Euronext European cash products ADV of 1.4 million transactions in September 2012 decreased 24.2% compared to September 2011 and increased 31.3% compared to August 2012.
- September 2012 market share in European Cash products was 68.7%, up from 65.7% in September 2011 and up from 68.2% in August 2012.
- In the third quarter of 2012, European cash products ADV of 1.3 million transactions was 30.9% below prior year levels.
- Year-to-date, European cash products ADV of 1.5 million transactions was 12.5% below prior year levels.
U.S. Cash
- NYSE Euronext U.S. cash products handled ADV in September 2012 decreased 34.7% to 1.7 billion shares compared to September 2011, but increased 15.4% from August 2012.
- In the third quarter of 2012, U.S. cash products handled ADV was 1.6 billion shares, down 39.3% from prior year levels.
- Year-to-date, U.S. cash products handled ADV was 1.7 billion shares, down 25.8% from prior year levels.
- NYSE Euronext’s Tape A matched market share in September 2012 was 31.1%, down from 36.3% in September 2011 and down from 31.6% in August 2012.
Exchange Traded Funds
- NYSE Euronext U.S. matched exchange-traded funds ADV (included in volumes for Tape B and Tape C) of 200 million shares in September 2012 decreased 52.5% compared to September 2011, but increased 19.2% compared to August 2012.
- In the third quarter of 2012, NYSE Euronext U.S. matched exchange-traded funds ADV of 186 million shares was 54.6% below prior year levels.
- Year-to-date, NYSE Euronext U.S. matched exchange-traded funds ADV of 215 million shares was 33.6% below prior year levels.
[1] All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.